Citigroup’s Kazia Therapeutics KZIA Stock Holding History

Citigroup’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$135K	Buy	+14,063	New	+$176K	﹤0.01%	4374
2026 Q1	–	Sell	-1	Closed	-$7	–	6180
2025 Q4	$7	Sell	1 -638	-100%	-$5.44K	﹤0.01%	5839
2025 Q3	$4.68K	Buy	+639	New	+$5.3K	﹤0.01%	5249
2025 Q1	–	Sell	-144	Closed	-$1.27K	–	5785
2024 Q4	$1.27K	Buy	+144	New	+$3.33K	﹤0.01%	5579
2022 Q2	–	Sell	-12	Closed	-$5K	–	6456
2022 Q1	$5K	Buy	+12	New	+$4.29K	﹤0.01%	5819
2016 Q2	–	Hold	0	–	–	–	7240
2016 Q1	–	Sell	-1	Closed	-$422	–	7606
2015 Q4	$0	Sell	1 -2	-67%	-$977	﹤0.01%	7712
2015 Q3	$2K	Sell	3 -6	-67%	-$3.89K	﹤0.01%	7028
2015 Q2	$7K	Sell	9 -4	-31%	-$4.54K	﹤0.01%	6622
2015 Q1	$11K	Buy	13 +6	+86%	+$3.44K	﹤0.01%	6421
2014 Q4	$3K	Buy	+7	New	+$3.47K	﹤0.01%	6791
2014 Q3	–	Hold	0	–	–	–	7185
2014 Q2	–	Hold	0	–	–	–	7226
2014 Q1	–	Sell	-2	Closed	-$1K	–	7113
2013 Q4	$1K	Buy	+2	New	+$1.92K	﹤0.01%	6863

Other funds holding KZIA

SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return

Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return

T3 Companies New York $103M AUM 54.73% 1-Year Est. Return

ORG Wealth Partners Dallas, Texas $607M AUM 23.88% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Citigroup's KZIA Position: Q3 2026 in Review

Citigroup opened a new position in Kazia Therapeutics (KZIA) in Q3 2026: 14,063 shares worth $135K. The stake represents ﹤0.01% of the portfolio and ranks #4374 among its holdings. This is a return to the name: Citigroup previously reported a position in KZIA as recently as Q4 2025.

Citigroup first reported a position in KZIA in Q4 2013 and has held it in 11 quarters since. 8 funds tracked by Wall St. Rank hold KZIA as of Q3 2026.

Citigroup held 14,063 shares of Kazia Therapeutics worth $135K as of Q3 2026.
Kazia Therapeutics was a new Citigroup position in Q3 2026.
Kazia Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #4374 holding.
Citigroup first reported a position in Kazia Therapeutics in Q4 2013 and has held it in 11 quarters since.
8 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.